Written by Craig Donald, head of analytical chemistry at Lucideon, and co-authored by Joseph Moss, analytical chemist at Lucideon, the paper discusses the importance of minimizing the risk of infection, from contaminated reusable devices, by assuring the validity of the cleaning and sterilization procedures used throughout manufacturing and reprocessing stages.

Craig said:

“It’s imperative that manufacturers have their reusable devices reprocessed correctly using specific, validated cleaning and sterilization methods, in order to prevent the passing of infection to other patients.”

Joseph added:

“Validation of cleaning methods produces procedures which are proven to effectively clean difficult soils from all parts of the device, including complex areas such as hinges or grooves.”

Lucideon provides testing, analysis and consultancy services to the healthcare sector.  Working closely with industry partners Lucideon helps to optimize, validate and innovate materials, processes and products.  With dedicated laboratories in the UK and US, Lucideon is a global supplier of healthcare solutions to a number of the world’s leading names.

The white paper can be downloaded via the Resources panel on this page.

To find out more about Lucideon's medical device cleaning and sterilization validation services please click here.